HSIC vs MCK vs VALN Stock Comparison

Henry Schein, Mckesson and Valneva SE Prices as of Nov 4, 2026 Peers: Industry group
1 more company in this comparison (MEDS) Create a free account to keep reading and compare up to 10 companies.
HSIC Henry Schein Inc
$88.24 +4.8% 1M +23.2% 1Y
Market cap
$9.75B
P/E
23.3x
Revenue (TTM)
$13.73B
Div. yield
–
Drug Distribution Healthcare
4 wins
MCK Mckesson Corp
$1,068.31 +16.6% 1M +26.9% 1Y
Market cap
$123.34B
P/E
26.4x
Revenue (TTM)
$418.79B
Div. yield
0.32%
Drug Distribution Healthcare
7 wins
VALN Valneva SE
$5.63 -3.3% 1M -38.0% 1Y
Market cap
$488.51M
P/E
–
Revenue (TTM)
$166.68M
Div. yield
–
Biotechnology Healthcare

Head to Head

11 decided of 12

Mckesson leads on 7 of the 12 questions below (Mckesson 7, Henry Schein 4). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionHSICMCKVALNLeader
Larger companyMarket capitalisation $9.75B $123.34B $488.51M MCK
Cheaper on earningsLower P/E, profitable companies only 23.3x 26.4x -3.5x HSIC
Cheaper on forward earningsLower price / next fiscal year consensus EPS 15.3x 22.7x — HSIC
Faster revenue growthRevenue growth, trailing twelve months +6.2% +8.2% -21.9% MCK
More profitableNet margin, trailing twelve months 3.1% 1.1% -80.6% HSIC
Better return on capitalReturn on invested capital 7.3% 98.7% -44.8% MCK
Less leveragedLower net debt / EBITDA 3.2x 0.4x — MCK
Higher dividend yieldTrailing dividend yield — 0.32% — –
Better 1-year returnPrice return, last 12 months +23.2% +26.9% -38.0% MCK
Better 5-year returnAnnualised price return, 5 years +2.0%/yr +37.0%/yr -32.7%/yr MCK
Less volatileAnnualised volatility, 1 year 25.0% 31.3% 71.2% HSIC
Higher overall scoreMean of the five percentile scores vs peers 54/100 61/100 34/100 MCK

Percentile Scorecard

HSICMCKVALN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisHSICMCKVALN
Valuation 44 #15 of 26 60 #11 of 26 57 #275 of 634
Growth 29 #18 of 25 63 #10 of 25 8 #556 of 607
Profitability 79 #6 of 25 67 #9 of 25 53 #263 of 557
Financial Health 16 #22 of 26 48 #14 of 26 21 #514 of 654
Shareholder Returns 100 #1 of 17 69 #6 of 17 33 #269 of 400
Overall 54 61 34
  • HSIC ranked among 27 companies in Healthcare Payers and Distributors
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • VALN ranked among 671 companies in Pharmaceuticals and Biotechnology

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodHSICMCKVALNSPY
1 month +4.8%+16.6%-3.3% -1.0%
3 months -1.5%+21.7%+6.8% -0.4%
6 months +21.8%+43.7%+4.1% +4.5%
Year to date +16.8%+30.2%-36.2% +12.4%
1 year +23.2%+26.9%-38.0% +13.6%
3 years +41.4%+136.0%-54.9% +76.4%
3 years, per year +12.3%+33.2%-23.3% +20.8%
5 years +10.2%+381.9%-86.2% +63.7%
5 years, per year +2.0%+37.0%-32.7% +10.4%
10 years +45.3%+717.0%— +267.7%
10 years, per year +3.8%+23.4%— +13.9%

Risk

MeasureHSICMCKVALNSPY
Volatility, 1Y 25.0%31.3%71.2% 12.8%
Downside volatility, 1Y 25.1%27.4%78.7% 12.7%
Beta vs S&P 500, 1Y 0.60-0.190.61 1.00
Return / volatility, 1Y 0.930.86-0.53 1.06
Max drawdown, 5Y -32.7%-27.2%-94.5% -25.4%
From 52-week high -2.9%0.0%-53.0% -1.6%
52-week high $90.86$1,068.31$11.99 $779.14
52-week low $68.99$725.17$4.78 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleHSICMCKVALN
P/E now vs peer median 23.3xmedian 25.7x 26.4xmedian 25.7x -3.5xmedian 18.0x
P/S now vs peer median 0.7xmedian 0.3x 0.3xmedian 0.3x 2.9xmedian 9.1x
EV/EBITDA now vs peer median 12.6xmedian 13.9x 16.9xmedian 13.9x —median 16.2x
P/FCF now vs peer median 17.4xmedian 16.6x 17.4xmedian 16.6x -7.2xmedian 21.7x
P/B now vs peer median 2.6xmedian 2.6x -31.2xmedian 2.6x 5.3xmedian 2.2x
PEG now vs peer median 6.89median 1.56 1.66median 1.56 0.01median 0.38

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsHSICMCKVALN
Revenue $13.73B $418.79B $166.68M
Gross profit $4.34B $15.37B $27.35M
Operating income $709.00M $6.69B -$134.30M
Net income $443.00M $5.43B -$183.90M
Free cash flow $559.00M $7.11B -$67.63M
R&D – – $96.94M
EPS (diluted) $3.74 $40.27 $-1.60
Cash & equivalents – $6.53B $138.81M
Total debt $3.52B $9.21B $210.28M
Shares (diluted) 112.54M 116.70M 84.09M
Enterprise value $10.48B $107.28B -$68.04M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricHSICMCKVALN
P/E 23.3x 26.4x -3.5x
P/FCF 17.4x 17.4x -7.2x
P/Operating cash flow 14.2x 16.4x -7.5x
P/S 0.7x 0.3x 2.9x
P/B 2.6x -31.2x 5.3x
P/Tangible book 3.4x -15.6x 7.1x
EV/EBITDA 12.6x 16.9x –
EV/EBIT 18.5x 18.8x -4.2x
EV/Revenue 1.0x 0.3x 3.4x
EV/FCF 23.4x 17.7x -8.3x
EV/Operating cash flow 19.1x 16.8x -8.6x
PEG (3Y EPS CAGR) 6.89 1.66 0.01

Growth

14 metrics
MetricHSICMCKVALN
Revenue growth (1Y) 6.2% 8.2% -21.9%
Revenue CAGR (3Y) 2.7% 12.9% -22.0%
Gross profit growth (1Y) 7.5% 11.8% -73.8%
Gross profit CAGR (3Y) 3.3% 7.6% -41.6%
Operating income growth (1Y) 9.9% 27.3% -146.1%
Operating income CAGR (3Y) 3.0% 16.1% -379.4%
Net income growth (1Y) 7.5% 28.5% -153.7%
Net income CAGR (3Y) -2.0% 14.2% -164.3%
EPS growth (1Y) 15.8% 24.2% -113.2%
EPS CAGR (3Y) 3.4% 15.9% -322.9%
Operating cash flow growth (1Y) 28.4% 9.3% -396.6%
Operating cash flow CAGR (3Y) -4.4% 15.2% 33.2%
Free cash flow growth (1Y) 38.7% 11.8% -154.4%
Free cash flow CAGR (3Y) -4.9% 16.3% 34.4%

Profitability

14 metrics
MetricHSICMCKVALN
Gross margin 31.6% 3.7% 16.4%
EBITDA margin 7.6% 1.8% –
Operating margin 5.2% 1.6% -80.6%
Pretax margin 4.2% 1.6% -110.3%
Net margin 3.1% 1.1% -80.6%
FCF margin 4.1% 1.7% -40.6%
Operating cash flow margin 5.0% 1.8% -38.9%
Return on equity 11.6% – -203.7%
Return on assets 3.9% 6.0% -42.3%
Return on invested capital 7.3% 98.7% -44.8%
Return on capital employed 9.0% 42.0% -42.4%
Asset turnover 1.2x 4.6x 0.4x
Cash conversion (OCF / net income) 1.6x 1.4x 0.4x
Stock comp / revenue 0.3% – –

Financial Health

11 metrics
MetricHSICMCKVALN
Debt / assets 30.6% 10.0% 47.4%
Debt / equity 0.9x -2.3x 2.3x
Net debt / EBITDA 3.2x 0.4x –
Debt / FCF 6.3x 1.3x -3.1x
Liabilities / assets 66.8% 104.3% 79.1%
Equity / assets 33.2% -4.3% 20.9%
Interest coverage 4.3x 21.9x -2.8x
Current ratio 1.3x 0.9x 2.2x
Quick ratio 0.6x 0.5x 1.3x
Cash ratio 0.1x 0.1x 1.2x
Altman Z-score 2.67 5.81 -1.87

Shareholder Returns

7 metrics
MetricHSICMCKVALN
Dividend yield – 0.3% –
Net buyback yield 6.6% 5.4% -10.8%
Shareholder yield 6.6% 5.7% -10.8%
Payout ratio (earnings) – 7.4% –
Payout ratio (FCF) – 5.6% –
Dividend growth (1Y) – 10.5% –
Dividend CAGR (3Y) – 9.8% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusHSICMCKVALN
Forward P/E 15.3xFY2026 22.7xFY2026 –
EPS, next fiscal year $5.75FY2026 $47.15FY2026 $-0.99FY2026
EPS growth, next FY +15.7%FY2026 +20.6%FY2026 –
EPS growth, the year after +8.2% +11.0% –
Revenue, next fiscal year $13.38BFY2026 $444.47BFY2026 $162.94MFY2026
Revenue growth, next FY +1.5%FY2026 +10.2%FY2026 -19.0%FY2026
Revenue growth, the year after +4.8% +1.5% +96.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersHSICMCKVALN
Held by institutions 100.0% 89.1% 4.4%
Institutions holding 566 2,014 20
Change in shares held, QoQ +2.1% -0.7% -3.3%
Institutions buying 245 883 13
Institutions selling 216 793 1
Buyers to sellers 1.13 1.11 13.00

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

HSICMCKVALN
HSIC 1.00 0.32 0.01
MCK 0.32 1.00 0.03
VALN 0.01 0.03 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, HSIC, MCK and VALN?

Mckesson (MCK) is the largest by market capitalisation: Henry Schein (HSIC) $9.75B, Mckesson (MCK) $123.34B, Valneva SE (VALN) $488.51M.

Which stock is cheaper, HSIC, MCK and VALN?

Henry Schein (HSIC) trades on the lowest price-to-earnings ratio (Henry Schein (HSIC) 23.3x, Mckesson (MCK) 26.4x, Valneva SE (VALN) -3.5x). On next year's consensus earnings, Henry Schein (HSIC) is cheapest (Henry Schein (HSIC) 15.3x, Mckesson (MCK) 22.7x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Mckesson (MCK) grew revenue fastest over the trailing twelve months: Henry Schein (HSIC) +6.2%, Mckesson (MCK) +8.2%, Valneva SE (VALN) -21.9%.

Which company is more profitable?

Henry Schein (HSIC) has the highest net margin (Henry Schein (HSIC) 3.1%, Mckesson (MCK) 1.1%, Valneva SE (VALN) -80.6%). On return on invested capital, Mckesson (MCK) leads (Henry Schein (HSIC) 7.3%, Mckesson (MCK) 98.7%, Valneva SE (VALN) -44.8%).

Which stock has performed better?

Over the past year Mckesson (MCK) returned the most: Henry Schein (HSIC) +23.2%, Mckesson (MCK) +26.9%, Valneva SE (VALN) -38.0%. Over five years, Mckesson (MCK) compounded fastest (Henry Schein (HSIC) +2.0%/yr, Mckesson (MCK) +37.0%/yr, Valneva SE (VALN) -32.7%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Mckesson (MCK) 0.32%. Henry Schein (HSIC) and Valneva SE (VALN) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Henry Schein (HSIC) has been the steadiest (Henry Schein (HSIC) 25.0%, Mckesson (MCK) 31.3%, Valneva SE (VALN) 71.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, HSIC, MCK and VALN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Mckesson (MCK) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.